Evaluation of Cyclophosphamide/GVAX Pancreas Followed by Listeria-mesothelin (CRS-207) With or Without Nivolumab in Patients with Pancreatic Cancer

PURPOSE: Two studies in previously-treated metastatic pancreatic cancer have been completed combining GVAX pancreas vaccine (granulocyte-macrophage colony-stimulating factor-secreting allogeneic pancreatic tumor cells) with cyclophosphamide (Cy) and CRS-207 (live, attenuated Listeria monocytogenes e...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Clin Cancer Res
Autori principali: Tsujikawa, Takahiro, Crocenzi, Todd, Durham, Jennifer N., Sugar, Elizabeth, Wu, Annie A., Onners, Beth, Nauroth, Julie M., Anders, Robert A., Fertig, Elana J., Laheru, Daniel A., Reiss, Kim A., Vonderheide, Robert H., Ko, Andrew H., Tempero, Margaret A., Fisher, George A., Considine, Michael, Danilova, Ludmila, Brockstedt, Dirk G., Coussens, Lisa M., Jaffee, Elizabeth M., Le, Dung T.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2020
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7727397/
https://ncbi.nlm.nih.gov/pubmed/32273276
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-19-3978
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi